Insider filing
Traded Jan 2 · filed 4 days later
Routine share withholding; mechanical by default.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 8, 2025 · Filed Dec 10, 2025
Century Therapeutics's See Remarks sold $280 of Century Therapeutics shares. The filing references tax withholding.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$280
Shares × reported transaction price
25 days after results of Nov 13, 2025, 94 days before results of Mar 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $0.57 on Dec 8, 2025, 46% above its 52-week low and 61% below its high, after a 1% drop over the previous 30 trading days
52-week range $0.3891 (Apr 8, 2025) to $1.47 (Dec 9, 2024), 17% of the way up, from 250 adjusted closes. 30 trading days earlier: $0.5773 on Oct 24, 2025. Describes the past only, not a forecast
RSI 59, 4% above its 200-day average, 5% above its 50-day average, 61% below the 52-week high, 20-day volatility 88% a year, against the S&P 500: +4 points over 1 month, +8 points over 3 months, −23 points over 6 months
From the adjusted closes up to Dec 8, 2025. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +29.0% | −1.8% | +30.9% |
| 30 days | +244.8% | +0.9% | +244.0% |
| 90 days | +361.5% | −1.9% | +363.3% |
| 180 days | +273.6% | +7.0% | +266.6% |
Past results only. Not a forecast.
Insider filing
Traded Jan 2 · filed 4 days later
Routine share withholding; mechanical by default.
Insider buying
Their first buy on recordTraded Dec 22, 2025 · filed 7 days later
Century Therapeutics's Chief Scientific Officer paid $49K out of pocket for Century Therapeutics shares. 1 other person at Century Therapeutics bought some too, in the same month. Shares held went up 6% with this purchase.
Insider buying
6 days before an 8-KTraded Dec 12, 2025 · filed 4 days later
The CEO of Century Therapeutics paid $30K out of pocket for Century Therapeutics shares. 1 other person at Century Therapeutics bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.